Exact Sciences Corp

EXAS

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

etfs

ARK Innovation ETF has likely been a disappointment for most investors

Investors are fleeing for the exits amid the fund's underperformance this year.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.708.20-0.10%
CAC 407,320.2334.370.47%
DAX 4021,278.6872.820.34%
Dow JONES (US)38,967.93797.522.09%
FTSE 1008,331.2855.620.67%
HKSE21,562.32167.180.78%
NASDAQ16,249.44378.542.39%
Nikkei 22534,220.6059.32-0.17%
NZX 50 Index11,836.69282.30-2.33%
S&P 5005,266.33108.132.10%
S&P/ASX 2007,816.702.40-0.03%
SSE Composite Index3,299.768.320.25%

Market Movers